Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke

被引:348
作者
Marder, Victor J.
Chute, Dennis J.
Starkman, Sidney
Abolian, Anna M.
Kidwell, Chelsea
Liebeskind, David
Ovbiagele, Bruce
Vinuela, Fernando
Duckwiler, Gary
Jahan, Reza
Vespa, Paul M.
Selco, Scott
Rajajee, Venkatakrishna
Kim, Dojin
Sanossian, Nerses
Saver, Jeffrey L.
机构
[1] Univ Calif Los Angeles, Orthoped Hosp, David Geffen Sch Med, Dept Med, Los Angeles, CA 90007 USA
[2] Univ Calif Los Angeles, Orthoped Hosp, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90007 USA
[3] Univ Calif Los Angeles, Orthoped Hosp, David Geffen Sch Med, Dept Emergency Med, Los Angeles, CA 90007 USA
[4] Univ Calif Los Angeles, Orthoped Hosp, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90007 USA
[5] Univ Calif Los Angeles, Orthoped Hosp, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90007 USA
[6] Univ Calif Los Angeles, Orthoped Hosp, David Geffen Sch Med, Div Neurosurg, Los Angeles, CA 90007 USA
关键词
cerebral arteries; thrombi;
D O I
10.1161/01.STR.0000230307.03438.94
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Information regarding the histological structure of thromboemboli that cause acute stroke provides insight into pathogenesis and clinical management. Methods-This report describes the histological analysis of thromboemboli retrieved by endovascular mechanical extraction from the middle cerebral artery (MCA) and intracranial carotid artery (ICA) of 25 patients with acute ischemic stroke. Results-The large majority (75%) of thromboemboli shared architectural features of random fibrin:platelet deposits interspersed with linear collections of nucleated cells (monocytes and neutrophils) and confined erythrocyte-rich regions. This histology was prevalent with both cardioembolic and atherosclerotic sources of embolism. "Red" clots composed uniquely of erythrocytes were uncommon and observed only with incomplete extractions, and cholesterol crystals were notably absent. The histology of thromboemboli that could not be retrieved from 29 concurrent patients may be different. No thrombus > 3 mm wide caused stroke limited to the MCA, and no thrombus > 5 mm wide was removed from the ICA. A mycotic embolus was successfully removed in 1 case, and a small atheroma and attached intima were removed without clinical consequence from another. Conclusions-Thromboemboli retrieved from the MCA or intracranial ICA of patients with acute ischemic stroke have similar histological components, whether derived from cardiac or arterial sources. Embolus size determines ultimate destination, those > 5 mm wide likely bypassing the cerebral vessels entirely. The fibrin:platelet pattern that dominates thromboembolic structure provides a foundation for both antiplatelet and anticoagulant treatment strategies in stroke prevention.
引用
收藏
页码:2086 / 2093
页数:8
相关论文
共 33 条
[1]   Guidelines for the early management of patients with ischemic stroke - A scientific statement from the Stroke Council of the American Stroke Association [J].
Adams, HP ;
Adams, RJ ;
Brott, T ;
del Zoppo, GJ ;
Furlan, A ;
Goldstein, LB ;
Grubb, RL ;
Higashida, R ;
Kidwell, C ;
Kwiatkowski, TG ;
Marler, JR ;
Hademenos, GJ .
STROKE, 2003, 34 (04) :1056-1083
[2]  
*AM HLTH ASS, 2003, HEART STROK FACTS
[3]   Heparin and oral anticoagulants in the treatment of brain ischemia [J].
Chaves, CJ ;
Caplan, LR .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 173 (01) :3-9
[4]   Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis [J].
Chimowitz, MI ;
Lynn, MJ ;
Howlett-Smith, H ;
Stern, BJ ;
Hertzberg, VS ;
Frankel, MR ;
Levine, SR ;
Chaturvedi, S ;
Kasner, SE ;
Benesch, CG ;
Sila, CA ;
Jovin, TG ;
Romano, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (13) :1305-1316
[5]   Transcatheter snare removal of acute middle cerebral artery thromboembolism: Technical case report [J].
Chopko, BW ;
Kerber, C ;
Wong, W ;
Georgy, B .
NEUROSURGERY, 2000, 46 (06) :1529-1531
[6]   Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial [J].
Clark, WM ;
Wissman, S ;
Albers, GW ;
Jhamandas, JH ;
Madden, KP ;
Hamilton, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2019-2026
[7]   RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE [J].
DELZOPPO, GJ ;
POECK, K ;
PESSIN, MS ;
WOLPERT, SM ;
FURLAN, AJ ;
FERBERT, A ;
ALBERTS, MJ ;
ZIVIN, JA ;
WECHSLER, L ;
BUSSE, O ;
GREENLEE, R ;
BRASS, L ;
MOHR, JP ;
FELDMANN, E ;
HACKE, W ;
KASE, CS ;
BILLER, J ;
GRESS, D ;
OTIS, SM .
ANNALS OF NEUROLOGY, 1992, 32 (01) :78-86
[8]   The Food and Drug Administration medical device review process -: Clearance of a clot retriever for use in ischemic stroke [J].
Felten, RP ;
Ogden, NRP ;
Peña, C ;
Provost, MC ;
Schlosser, MJ ;
Witten, CM .
STROKE, 2005, 36 (02) :404-406
[9]  
Fourie P, 2003, AM J NEURORADIOL, V24, P630
[10]   MERCI 1 - A phase 1 study of mechanical embolus removal in cerebral ischemia [J].
Gobin, YP ;
Starkman, S ;
Duckwiler, GR ;
Grobelny, T ;
Kidwell, CS ;
Jahan, R ;
Pile-Spellman, J ;
Segal, A ;
Vinuela, F ;
Saver, JL .
STROKE, 2004, 35 (12) :2848-2853